Literature DB >> 22514310

Memory deficits of British dementia knock-in mice are prevented by Aβ-precursor protein haploinsufficiency.

Robert Tamayev1, Luciano D'Adamio.   

Abstract

Familial British Dementia (FBD) is caused by an autosomal dominant mutation in the BRI2/ITM2B gene (Vidal et al., 1999). FBD(KI) mice are a model of FBD that is genetically congruous to the human disease, because they carry one mutant and one wild-type Bri2/Itm2b allele. Analysis of these mice has shown that the British mutation causes memory impairments due to loss of Bri2 function (Tamayev et al., 2010b). BRI2 is a physiologic inhibitor of processing of the Aβ-precursor protein (APP; Matsuda et al., 2008), a gene associated with Alzheimer's disease (Bertram et al., 2010). Here we show that APP haploinsufficiency prevents memory dysfunctions seen in FBD(KI) mice. This genetic suppression is consistent with a role for APP in the pathogenesis of memory deficits. Moreover, it provides compelling evidence that the memory dysfunctions caused by the British BRI2 mutant are dependent on endogenous APP and that BRI2 and APP functionally interact. This evidence establishes a mechanistic connection between Familial British and Alzheimer's dementias.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22514310      PMCID: PMC3338198          DOI: 10.1523/JNEUROSCI.5193-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  23 in total

1.  Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta.

Authors:  Janice L Holton; Tammaryn Lashley; Jorge Ghiso; Hans Braendgaard; Ruben Vidal; Christopher J Guerin; Graham Gibb; Diane P Hanger; Agueda Rostagno; Brian H Anderton; Catherine Strand; Hilary Ayling; Gordon Plant; Blas Frangione; Marie Bojsen-Møller; Tamas Revesz
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

2.  Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease.

Authors:  Agueda Rostagno; Tamas Revesz; Tammaryn Lashley; Yasushi Tomidokoro; Laura Magnotti; Hans Braendgaard; Gordon Plant; Marie Bojsen-Møller; Janice Holton; Blas Frangione; Jorge Ghiso
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

3.  Axonal transport of British and Danish amyloid peptides via secretory vesicles.

Authors:  Seung-Il Choi; Ruben Vidal; Blas Frangione; Efrat Levy
Journal:  FASEB J       Date:  2003-12-04       Impact factor: 5.191

4.  Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.

Authors:  Fabrizio Trinchese; Shumin Liu; Fortunato Battaglia; Sean Walter; Paul M Mathews; Ottavio Arancio
Journal:  Ann Neurol       Date:  2004-06       Impact factor: 10.422

5.  Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia.

Authors:  J L Holton; J Ghiso; T Lashley; A Rostagno; C J Guerin; G Gibb; H Houlden; H Ayling; L Martinian; B H Anderton; N W Wood; R Vidal; G Plant; B Frangione; T Revesz
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

6.  A stop-codon mutation in the BRI gene associated with familial British dementia.

Authors:  R Vidal; B Frangione; A Rostagno; S Mead; T Révész; G Plant; J Ghiso
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

7.  Exposing rats to a predator impairs spatial working memory in the radial arm water maze.

Authors:  D M Diamond; C R Park; K L Heman; G M Rose
Journal:  Hippocampus       Date:  1999       Impact factor: 3.899

8.  The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production.

Authors:  Shuji Matsuda; Luca Giliberto; Yukiko Matsuda; Peter Davies; Eileen McGowan; Fiona Pickford; Jorge Ghiso; Blas Frangione; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2005-06-27       Impact factor: 5.157

9.  Proteolytic processing of familial British dementia-associated BRI variants: evidence for enhanced intracellular accumulation of amyloidogenic peptides.

Authors:  Seong-Hun Kim; John W M Creemers; Su Chu; Gopal Thinakaran; Sangram S Sisodia
Journal:  J Biol Chem       Date:  2001-11-14       Impact factor: 5.157

10.  β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia.

Authors:  Robert Tamayev; Shuji Matsuda; Ottavio Arancio; Luciano D'Adamio
Journal:  EMBO Mol Med       Date:  2012-01-23       Impact factor: 12.137

View more
  14 in total

1.  BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells.

Authors:  M Del Campo; C R Oliveira; W Scheper; R Zwart; C Korth; A Müller-Schiffmann; G Kostallas; H Biverstal; J Presto; J Johansson; J J Hoozemans; C F Pereira; C E Teunissen
Journal:  Cell Mol Life Sci       Date:  2014-10-22       Impact factor: 9.261

2.  Amyloid and intracellular accumulation of BRI2.

Authors:  Holly J Garringer; Neeraja Sammeta; Adrian Oblak; Bernardino Ghetti; Ruben Vidal
Journal:  Neurobiol Aging       Date:  2016-12-29       Impact factor: 4.673

3.  Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease.

Authors:  Claudia H Huichalaf; Ismael Al-Ramahi; Kyung-Won Park; Stacy D Grunke; Nan Lu; Maria de Haro; Karla El-Zein; Tatiana Gallego-Flores; Alma M Perez; Sung Yun Jung; Juan Botas; Huda Y Zoghbi; Joanna L Jankowsky
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

4.  The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.

Authors:  Beverly W Baron; Rebecca M Baron; Joseph M Baron
Journal:  Biochim Biophys Acta       Date:  2014-12-31

5.  The Familial British Dementia Mutation Promotes Formation of Neurotoxic Cystine Cross-linked Amyloid Bri (ABri) Oligomers.

Authors:  Adam Cantlon; Carlo Sala Frigerio; Darragh B Freir; Barry Boland; Ming Jin; Dominic M Walsh
Journal:  J Biol Chem       Date:  2015-05-08       Impact factor: 5.157

6.  Amyloid beta precursor protein and prion protein have a conserved interaction affecting cell adhesion and CNS development.

Authors:  Darcy M Kaiser; Moulinath Acharya; Patricia L A Leighton; Hao Wang; Nathalie Daude; Serene Wohlgemuth; Beipei Shi; W Ted Allison
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

7.  Abolishing Tau cleavage by caspases at Aspartate421 causes memory/synaptic plasticity deficits and pre-pathological Tau alterations.

Authors:  F Biundo; C d'Abramo; M D Tambini; H Zhang; D Del Prete; F Vitale; L Giliberto; O Arancio; L D'Adamio
Journal:  Transl Psychiatry       Date:  2017-08-08       Impact factor: 6.222

8.  Lessons from a Rare Familial Dementia: Amyloid and Beyond.

Authors:  Adam Cantlon; Carlo Sala Frigerio; Dominic M Walsh
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2015-08

9.  APP is cleaved by Bace1 in pre-synaptic vesicles and establishes a pre-synaptic interactome, via its intracellular domain, with molecular complexes that regulate pre-synaptic vesicles functions.

Authors:  Dolores Del Prete; Franco Lombino; Xinran Liu; Luciano D'Adamio
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

10.  Deletion of the γ-secretase subunits Aph1B/C impairs memory and worsens the deficits of knock-in mice modeling the Alzheimer-like familial Danish dementia.

Authors:  Fabrizio Biundo; Keita Ishiwari; Dolores Del Prete; Luciano D'Adamio
Journal:  Oncotarget       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.